A prospective randomized phase III trial comparing trimodality therapy (cisplatin, 5-FU [fluorouracil], radiotherapy, and surgery) to surgery alone for esophageal cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Fluorouracil
- Indications Oesophageal cancer
- Focus Therapeutic Use
- Acronyms ICE-T
- 04 Jul 2016 Biomarkers information updated
- 27 Sep 2013 Additional lead trial centre added as reported by ClinicalTrials.gov.
- 02 Mar 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.